Calistoga Pharmaceuticals' Series A Round

Calistoga Pharmaceuticals raised a round of funding on January 14, 2008.

Calistoga Pharmaceuticals is a biopharmaceutical company developing multiple compounds selectively targeting the PI3K pathway, a pathway known to be involved in certain cancers and inflammatory diseas…

Articles about Calistoga Pharmaceuticals' Series A Round: